Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV - Wikidata - wikimedia - TriplyDB

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

http://www.wikidata.org/entity/Q28235281

about

Clinical development of gene therapy: results and lessons from recent successes Targeting the latent reservoir to achieve functional HIV cure In Vivo Delivery Systems for Therapeutic Genome Editing Customizing the genome as therapy for the β-hemoglobinopathies Genome Engineering with TALE and CRISPR Systems in Neuroscience The therapeutic potential of genome editing for β-thalassemia How to Define the Latent Reservoir: Tools of the Trade Genome-editing Technologies for Gene and Cell Therapy Gene therapy: progress and predictions Towards a new era in medicine: therapeutic genome editing Synthetic biology devices for in vitro and in vivo diagnostics Origins of Programmable Nucleases for Genome Engineering Application of CRISPR/Cas9 Technology to HBV Single-Base Pair Genome Editing in Human Cells by Using Site-Specific Endonucleases Enabling functional genomics with genome engineering The complexity of epigenetic diseases Cell-based therapy technology classifications and translational challenges Engineered Viruses as Genome Editing Devices Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus Synthetic biology approaches to engineer T cells Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street Progress toward curing HIV infection with hematopoietic cell transplantation CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape Synthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases Progress and prospects for engineered T cell therapies Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9 Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.The potential for tumor suppressor gene therapy in head and neck cancer Genome editing: the road of CRISPR/Cas9 from bench to clinic Stem cell transplantation in strategies for curing HIV/AIDS Hematopoietic Stem Cells in Regenerative Medicine: Astray or on the Path?Achieving HIV-1 Control through RNA-Directed Gene Regulation T cell engineering as therapy for cancer and HIV: our synthetic future Engineering T Cells to Functionally Cure HIV-1 Infection Therapeutic genome editing: prospects and challenges Development and applications of CRISPR-Cas9 for genome engineering.CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice

P2860

Q26743393-F60D07EA-C2F7-4939-9E0E-B3CE9A4E0BD0 Q26745923-6F423302-18EF-47FC-88BF-AA9BF9432EC3 Q26748886-5D62493D-016E-42F0-A861-CF46FFD1D03C Q26751061-B909403C-B04C-4FB2-BD34-986FCFB12AF7 Q26752488-45876D50-2733-4AA4-A616-E8DC0C1110F8 Q26766232-FAA0930F-2500-4150-B673-868A2358117F Q26766705-B2A0B654-0EDA-4BE9-A818-C203B6A5D5AC Q26769662-2BB68155-23AE-4047-8AF9-9C5BD259E28A Q26772109-357C2E55-B154-4641-A7CD-5F73AF49C73D Q26773287-131E82EA-B5BD-44C2-A6EA-78BA2AB8BC6C Q26776378-6D14951A-E9F7-4511-9401-F923929A3AAA Q26778501-DCCC43D6-A307-4686-8B93-41848F56A2F6 Q26779150-77A80C1B-D27F-4C76-9A70-B85C410BBA10 Q26781370-06370237-68E4-424B-8435-1524DE5584C2 Q26782747-A67B4F42-B273-478C-BA9A-5570EA9B4DD9 Q26784416-3A7A49B9-4797-4D96-864C-2B82E21DA6E9 Q26785346-403F8168-079B-44C5-9696-69DB1B1A63DB Q26785927-310A0899-8B39-4A0E-B2F7-51098743D71C Q26797870-7E0E8613-C87C-420C-BC0B-EF811BF8AED3 Q26798366-CBE98ADE-17A1-476D-848B-F5D22DA4750D Q26799357-15A6B64F-057C-4CCC-B5E6-9AD5C3556BA4 Q26801269-B728EB09-6C49-4DF3-914B-2457A510C887 Q26801498-32BF087B-4078-4C94-A9F8-3E5A13ABAB1F Q26830610-65C12208-175A-4AD5-BA02-3B68D4F13C7B Q26852923-7242A92A-844D-4CF7-A1D1-E2C9635BB4DC Q27011249-9B3D721F-2207-4A85-AE68-025DE66B15B1 Q27011906-C974F1EA-13B0-47FD-B612-8B458CE79A74 Q27318042-CD571928-975E-4888-B637-7F2C6BBFEFCE Q28066254-D78FBFCF-ED97-45EE-8065-8BDEB7276F5B Q28066970-43108F90-E44C-4826-8947-8CD432717DC6 Q28069423-9C5B4D0E-5BAE-4CFE-84F1-21C265B5740C Q28072887-5F4290BE-CA76-46F5-B052-682B8707F4F8 Q28080090-D6B98306-B229-4156-80D2-1CFD9CB7D286 Q28082253-84400564-17E3-4B49-9578-ED5B76BD299E Q28086801-0A8429EF-C286-46B2-A350-D0BBA4C76C76 Q28087380-618E2A96-6A22-47BA-AB10-FBDE948CCD25 Q28241526-ECDB6225-5E5D-44AB-8594-6143CA928BE2 Q28542878-CDA81BB1-B703-4833-A1BC-EBDA959180F1 Q28552171-C82DF19B-F418-4DD7-B13F-AC478F05DC1F Q28607258-E39F5094-22B7-4446-A47D-5A341DAD207E

P2860

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

http://www.wikidata.org/entity/Q28235281

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@ast

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@en

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@nl

type

label

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@ast

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@en

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@nl

prefLabel

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@ast

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@en

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@nl

P1433

Q28235281-C85B1321-006C-48BE-9F46-1DCD0CDDEC53

P1476

Q28235281-14BB4CE5-5D5A-4763-A4AE-11340B663C7F

P2093

Q28235281-28B66D41-163E-491B-B491-B27175960925

Q28235281-2C54D878-D377-45A7-AE74-BF25A643F251

Q28235281-300241E9-D3A1-4651-AAC2-536874B314FE

Q28235281-3AD7A1CA-D161-4D17-B643-9478F83E13C0

Q28235281-46B8D257-E83C-4D38-81F0-7BD634C5B393

Q28235281-63AD55A8-F5C9-45D2-8A0C-F9760C26718B

Q28235281-82A01FE8-5E95-4087-8541-0AB07AA66996

Q28235281-8A1ECDDF-1F81-47A8-B6C6-EDE3041CFAFC

Q28235281-9091EAD1-C1E7-430A-9D07-A314CFF8D94C

Q28235281-95D91672-89AE-4D3C-B694-DF4BE4E1F80A

P2860

Q28235281-02E7F40D-08F8-47E7-8CE3-9D623528DA49

Q28235281-041D7C6A-8A67-4BB7-8BF0-FCA2BE4E14CF

Q28235281-2CC70ABD-C6D1-4014-85FB-BC8BD69ECED5

Q28235281-3EEBCEE2-2F9A-49D0-9C04-859004522198

Q28235281-405515B3-4BAC-49DB-9B2E-73E2A86167BE

Q28235281-42BA5FBE-31C8-4D33-AA9B-FCF756DE2035

Q28235281-58BC3BAE-6A17-4E7F-BF95-4B20590F6F78

Q28235281-61263881-30D7-4A8B-B3F4-1FAA24A9DF9F

Q28235281-613E5EC0-A75F-42A7-B104-DFBDF79DA5DF

Q28235281-6D5F1595-1B50-4AB7-BDDA-F6DA392FD217

P304

Q28235281-F76B8999-BD5E-47BC-96FF-FEDD390766D3

P31

Q28235281-13BC821E-D86D-4200-AC20-814570DA9836

P3181

Q28235281-2E8B6061-7158-490F-99BF-7BCEF3C3AA47

P356

Q28235281-E791FF0C-305D-4AA1-9F61-E320520C1CC8

P407

Q28235281-6239C29F-6A68-41DC-A683-17CCF5D6546B

P433

Q28235281-252636BA-B7BD-418D-A60C-4DDCF9C519EC

P478

Q28235281-BE4E915C-CA6A-4EE2-BC6D-1649498394DD

P50

Q28235281-43348EF7-71D4-4427-81EB-3CA4E6E50262

Q28235281-665033BA-0FA9-4191-AF19-18A6A21DB96C

Q28235281-9C014326-1A4B-43DC-A0BC-F59F0B4B4177

P577

Q28235281-CAFEF703-EF50-48A9-8E84-F94E9B402AC8

P698

Q28235281-7F397CA5-F578-4834-A0E1-387BE417BB9A

P921

Q28235281-C7E25E78-BB9E-422F-8A79-0C1116B177CE

P932

Q28235281-9B381DD3-D517-4951-B864-41C820EF0A97

P3181

P356

P1433

The New England Journal of Medicine

P1476

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

@en

P2093

Bruce L Levine

http://www.w3.org/2001/XMLSchema#string

Carl H June

http://www.w3.org/2001/XMLSchema#string

Dale G Ando

http://www.w3.org/2001/XMLSchema#string

David Stein

http://www.w3.org/2001/XMLSchema#string

Gabriela Plesa

http://www.w3.org/2001/XMLSchema#string

Gary Lee

http://www.w3.org/2001/XMLSchema#string

Geoff Nichol

http://www.w3.org/2001/XMLSchema#string

Gwendolyn Binder-Scholl

http://www.w3.org/2001/XMLSchema#string

Ian Frank

http://www.w3.org/2001/XMLSchema#string

Martin A Giedlin

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging concepts in the immunopathogenesis of AIDS

Identification of a major co-receptor for primary isolates of HIV-1

Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes

Computational redesign of endonuclease DNA binding and cleavage specificity

FokI dimerization is required for DNA cleavage

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

Genome editing with engineered zinc finger nucleases

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

Can HIV be cured with stem cell therapy?

P304

901-910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1255475

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1300662

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

370

http://www.w3.org/2001/XMLSchema#string

P50

Philip D Gregory

Ronald G Collman

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24597865

http://www.w3.org/2001/XMLSchema#string

P921

P932

4084652

http://www.w3.org/2001/XMLSchema#string